Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global Biopharmaceutical Contract Manufacturing Market Report 2018

Single User: $4880
Multiple User: $7320
Enterprise User: $9760


Report Summary:

A contract manufacturer ("CM") is a manufacturer that contracts with a firm for components or products. It is a form of outsourcing. A contract manufacturer performing packaging operations is called copacker or a contract packager.

Scope of the Report:
This report studies the Biopharmaceutical Contract Manufacturing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biopharmaceutical Contract Manufacturing market by product type and applications/end industries.
In terms of application, the global biopharmaceutical contract manufacturing market is divided into several sections. Among them, oncology is the biggest downstream user who has a market share of 21.3% in 2017.
The global Biopharmaceutical Contract Manufacturing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biopharmaceutical Contract Manufacturing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
Lonza Group
Baxter Biopharma Solutions
Samsung
Fujifilm Diosynth Biotechnologies
Boehringer Ingelheim
Patheon
Rentschler Biotechnologie
Biomeva
Probiogen
Cytovance Biologics
KBI Biopharma
WuXi Biologics
Abzena

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Growth Factors
Interferons
Monoclonal Antibodies
Recombinant Hormones
Vaccines
Insulin
Others

Market Segment by Applications, can be divided into
Autoimmune Diseases
Oncology
Metabolic Diseases
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Neurology
Respiratory Disorders
Others

Table of Contents / Index:

Table of Contents

1 Biopharmaceutical Contract Manufacturing Market Overview
1.1 Product Overview and Scope of Biopharmaceutical Contract Manufacturing
1.2 Classification of Biopharmaceutical Contract Manufacturing by Types
1.2.1 Global Biopharmaceutical Contract Manufacturing Revenue Comparison by Types (2017-2023)
1.2.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Types in 2017
1.2.3 Growth Factors
1.2.4 Interferons
1.2.5 Monoclonal Antibodies
1.2.6 Recombinant Hormones
1.2.7 Vaccines
1.2.8 Insulin
1.2.9 Others
1.3 Global Biopharmaceutical Contract Manufacturing Market by Application
1.3.1 Global Biopharmaceutical Contract Manufacturing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Metabolic Diseases
1.3.5 Ophthalmology
1.3.6 Cardiovascular Diseases
1.3.7 Infectious Diseases
1.3.8 Neurology
1.3.9 Respiratory Disorders
1.3.10 Others
1.4 Global Biopharmaceutical Contract Manufacturing Market by Regions
1.4.1 Global Biopharmaceutical Contract Manufacturing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biopharmaceutical Contract Manufacturing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical Contract Manufacturing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical Contract Manufacturing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biopharmaceutical Contract Manufacturing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical Contract Manufacturing Status and Prospect (2013-2023)
1.5 Global Market Size of Biopharmaceutical Contract Manufacturing (2013-2023)
2 Manufacturers Profiles
2.1 Lonza Group
2.1.1 Business Overview
2.1.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Baxter Biopharma Solutions
2.2.1 Business Overview
2.2.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Samsung
2.3.1 Business Overview
2.3.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Samsung Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Fujifilm Diosynth Biotechnologies
2.4.1 Business Overview
2.4.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Patheon
2.6.1 Business Overview
2.6.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Patheon Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Rentschler Biotechnologie
2.7.1 Business Overview
2.7.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biomeva
2.8.1 Business Overview
2.8.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biomeva Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Probiogen
2.9.1 Business Overview
2.9.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Probiogen Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cytovance Biologics
2.10.1 Business Overview
2.10.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.11 KBI Biopharma
2.11.1 Business Overview
2.11.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.12 WuXi Biologics
2.12.1 Business Overview
2.12.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
2.13 Abzena
2.13.1 Business Overview
2.13.2 Biopharmaceutical Contract Manufacturing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Abzena Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biopharmaceutical Contract Manufacturing Market Competition, by Players
3.1 Global Biopharmaceutical Contract Manufacturing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biopharmaceutical Contract Manufacturing Players Market Share
3.2.2 Top 10 Biopharmaceutical Contract Manufacturing Players Market Share
3.3 Market Competition Trend
4 Global Biopharmaceutical Contract Manufacturing Market Size by Regions
4.1 Global Biopharmaceutical Contract Manufacturing Revenue and Market Share by Regions
4.2 North America Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
4.3 Europe Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
4.5 South America Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
5 North America Biopharmaceutical Contract Manufacturing Revenue by Countries
5.1 North America Biopharmaceutical Contract Manufacturing Revenue by Countries (2013-2018)
5.2 USA Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
5.3 Canada Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
5.4 Mexico Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
6 Europe Biopharmaceutical Contract Manufacturing Revenue by Countries
6.1 Europe Biopharmaceutical Contract Manufacturing Revenue by Countries (2013-2018)
6.2 Germany Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
6.3 UK Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
6.4 France Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
6.5 Russia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
6.6 Italy Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Countries
7.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Countries (2013-2018)
7.2 China Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
7.3 Japan Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
7.4 Korea Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
7.5 India Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
8 South America Biopharmaceutical Contract Manufacturing Revenue by Countries
8.1 South America Biopharmaceutical Contract Manufacturing Revenue by Countries (2013-2018)
8.2 Brazil Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
8.3 Argentina Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
8.4 Colombia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biopharmaceutical Contract Manufacturing by Countries
9.1 Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
9.3 UAE Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
9.4 Egypt Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
9.6 South Africa Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2013-2018)
10 Global Biopharmaceutical Contract Manufacturing Market Segment by Type
10.1 Global Biopharmaceutical Contract Manufacturing Revenue and Market Share by Type (2013-2018)
10.2 Global Biopharmaceutical Contract Manufacturing Market Forecast by Type (2018-2023)
10.3 Growth Factors Revenue Growth Rate (2013-2023)
10.4 Interferons Revenue Growth Rate (2013-2023)
10.5 Monoclonal Antibodies Revenue Growth Rate (2013-2023)
10.6 Recombinant Hormones Revenue Growth Rate (2013-2023)
10.7 Vaccines Revenue Growth Rate (2013-2023)
10.8 Insulin Revenue Growth Rate (2013-2023)
10.9 Others Revenue Growth Rate (2013-2023)
11 Global Biopharmaceutical Contract Manufacturing Market Segment by Application
11.1 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2013-2018)
11.2 Biopharmaceutical Contract Manufacturing Market Forecast by Application (2018-2023)
11.3 Autoimmune Diseases Revenue Growth (2013-2018)
11.4 Oncology Revenue Growth (2013-2018)
11.5 Metabolic Diseases Revenue Growth (2013-2018)
11.6 Ophthalmology Revenue Growth (2013-2018)
11.7 Cardiovascular Diseases Revenue Growth (2013-2018)
11.8 Infectious Diseases Revenue Growth (2013-2018)
11.9 Neurology Revenue Growth (2013-2018)
11.10 Respiratory Disorders Revenue Growth (2013-2018)
11.11 Others Revenue Growth (2013-2018)
12 Global Biopharmaceutical Contract Manufacturing Market Size Forecast (2018-2023)
12.1 Global Biopharmaceutical Contract Manufacturing Market Size Forecast (2018-2023)
12.2 Global Biopharmaceutical Contract Manufacturing Market Forecast by Regions (2018-2023)
12.3 North America Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2018-2023)
12.4 Europe Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2018-2023)
12.6 South America Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 40181

Category: 11

Published date: 2018-06-18 07:07:11

Number of Pages: 129

Publisher Name: GIR

Over all Rating: 87 % (Average of Ratings provided by clients)